Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

NCT00348309 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1496

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Rosiglitazone Extended Release 2mg
DRUG: Rosiglitazone Extended Release 8mg
OTHER: Placebo
OTHER: Donepezil

Sponsor

GlaxoSmithKline